Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at Kidney Week 2024 ...Middle East

– Pooled analysis from Phase 3 clinical trials highlights liver transplant rates in adult patients with HRS with rapid reduction in kidney function treated with TERLIVAZ1 – DUBLIN, Oct. 26, 2024 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced a...

Hence then, the article about mallinckrodt presents data on terlivaz terlipressin for injection in patients with hepatorenal syndrome hrs at kidney week 2024 was published today ( Saturday 26/10/2024 - 08:17 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at Kidney Week 2024 )

Also on site :

• Trump DOJ Refuses to Rule Out Second Amendment Right to Nuclear Weapons
• 53-year-old woman accused of stripping naked and assaulting customers in a Pennsylvania grocery store
• Is Europe heading to an energy crisis?